Alcresta Therapeutics
formerly AlcrestaAcquiredEnzyme products designed for enteral nutrition
Alcresta Therapeutics is headquartered in United States, lists 11–50 employees, and has $118.4M in recorded funding across 4 rounds.
- Headquarters
- Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Website
- alcresta.com
- Total Funding
- $118.4M
- Last Round
- $49.0M Series CJun 2016
- Rounds
- 4
- Acquisition Date
- Mar 2024
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 6 investors for this company. The full record is or through the API.
About
Alcresta Therapeutics is a Massachusetts-based rare disease company dedicated to developing and commercializing novel enzyme-based products that improve nutritional care for enterally fed patients. The company's flagship product, RELiZORB, is the only FDA-cleared enzymatic product studied and indicated for use with enteral feeding, utilizing Alcresta's proprietary iLipase immobilized enzyme technology to address fat malabsorption in patients with conditions such as cystic fibrosis and pancreatic insufficiency. Backed by Linden Capital Partners and HealthQuest Capital, Alcresta has built an extensive intellectual property portfolio while advancing a pipeline of additional enzyme-based solutions for rare gastrointestinal disorders.
Summary
Alcresta Therapeutics is a Biotech company based in United States. It lists 11–50 employees. It has raised $118.4M in total across 4 rounds, most recently a $49.0M Series C round in Jun 2016. Investors include Bessemer Venture Partners, Linden Capital Partners and Third Rock Ventures.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Mar 2024
Sign up to see all 5 events
Funding: Series A through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alcresta-therapeutics"><img src="https://indexed.vc/api/badge/company/alcresta-therapeutics" alt="Alcresta Therapeutics on Indexed.vc" width="260" height="76" /></a>